Postoperative chemotherapy in gastric cancer, consisting of etoposide, doxorubicin and cisplatin, followed by radiotherapy with concomitant cisplatin: A feasibility study

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 1154-1158

  Shulman, Katerina ^a   Haim, Nissim ^a   Wollner, Mira ^a   Bernstein, Zvi ^a   Abdah Bortnyak, Roxylana ^a   Bar Sela, Gil ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Adjuvant chemo radiotherapy; Adriamycin; Cisplatin; Etoposide; Gastric cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE;

ABDOMINAL PAIN; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DIARRHEA; ESOPHAGITIS; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEARING LOSS; HUMAN; INFECTION; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SENSORY NEUROPATHY; STOMACH CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84857958988     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.617     Document Type: Article

References (15)

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA and Hamilton SM: Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg 241: 27-39, 2005.
2. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001.
3. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for respectable gastroesophageal junction carcinoma. N Engl J Med 355: 11-20, 2006.
4. Goburn NG, Govindarajan A, Law CH, et al: Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients. Ann Surg Oncol 15: 500-507, 2008.
5. Fiorica F, Cartei F, Enea M, et al: The impact of radiotherapy on survival in respectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev 33: 729-740, 2007.
6. Lim L, Michael M, Mann GB and Leong T: Adjuvant therapy in gastric cancer. J Clin Oncol 23: 6220-6232, 2005.
7. Haim N, Tsalik M and Robinson E: Treatment of gastric adeno-carcinoma with combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules. Oncology 51: 102-107, 1994.
8. Bar-Sela G, Tsalic M, Steiner M, Wollner M and Haim N: Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesopha-geal junction adenocarcinoma. Anticancer Res 29: 1853-1856, 2009.
9. Leong T, Joon DL, Willis D, et al: Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys 79: 690-695, 2011.
10. Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, et al: Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. J Cancer Res Clin Oncol 135: 163-172, 2009.
11. Orditura M, De Vita F, Muto P, Vitiello F, Murino P, Lieto E, Vecchione L, et al: Adjuvant chemoradiotherapy in patients with stage III or IV radically resected gastric cancer: a pilot study. Arch Surg 145: 233-238, 2010.
12. Fuchs C, Tepper J, et al: Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LCV before and after CRT: intergroup Trial CALGB 80101. ASCO abstract 4003, 2011.
13. Schwartz G, Winter K, Minsky BD, et al: Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). J Clin Oncol 27: 1956-1962, 2009.
14. Bamias A, Karina M, Papakostas P, et al: A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol 65: 1009-1021, 2010.
15. Bang Y, Kim Y, et al: Adjuvant capecitabine and oxaliplatin for gastric cancer: results of the phase III CLASSIC Trial. ASCO abs. 4002, 2011.